Biolase, Inc.

The momentum for this stock is not very good. Biolase, Inc. is not a good value stock. Biolase, Inc. is not very popular among insiders. Biolase, Inc. is a mediocre stock to choose.

BIOLASE, Inc. is a medical device company, which engages in the development, manufacture, market and...

News

BIOLASE Reports 2024 Second Quarter Results; Achieves 40% Gross Margin as Global Consumable Sales Strengthen

Accesswire LAKE FOREST, CA / ACCESSWIRE / August 8, 2024 / BIOLASE, Inc. (NASDAQ:BIOL), a leader in dental laser technology, today reported its financial results for the second quarter ended June 30, 2024.'We...\n more…

BIOLASE announces delisting from Nasdaq

SeekingAlpha.com: All News BIOLASE (BIOL) faces delisting from Nasdaq due to failure to meet listing requirements.\n more…

Biolase announces delisting from Nasdaq

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

BIOLASE Announces Delisting from Nasdaq

Accesswire LAKE FOREST, CA / ACCESSWIRE / June 18, 2024 / BIOLASE, Inc. (NASDAQ:BIOL), a global leader in dental lasers, today announced that the Company received a notice from Nasdaq that it has determined to...\n more…

BIOLASE, Inc. (BIOL) Q1 2024 Earnings Call Transcript

Seeking Alpha: Transcripts BIOLASE, Inc. (BIOL) Q1 2024 Earnings Call Transcript...\n more…

BIOL Stock Earnings: Biolase Misses EPS, Beats Revenue for Q1 2024

InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nBIOL stock results show that Biolase missed analyst estimates for earnings per share but beat on revenue for the first quarter of...\n more…